Literature DB >> 15777567

Management of complications of cirrhosis in patients awaiting liver transplantation.

Andres Cardenas1, Pere Ginès.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15777567     DOI： 10.1016/j.jhep.2004.12.007

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  10 in total

Review 1.  Integration of palliative care in end-stage liver disease and liver transplantation.

Authors:  Jamie Potosek; Michael Curry; Mary Buss; Eva Chittenden
Journal:  J Palliat Med       Date:  2014-11       Impact factor: 2.947

Review 2.  The management of patients awaiting liver transplantation.

Authors:  Ka-Kit Li; James Neuberger
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-10-06       Impact factor: 46.802

3.  Prognostic indicators of survival in patients with compensated and decompensated cirrhosis.

Authors:  Alexander Zipprich; Guadalupe Garcia-Tsao; Sebastian Rogowski; Wolfgang E Fleig; Thomas Seufferlein; Matthias M Dollinger
Journal:  Liver Int       Date:  2012-06-11       Impact factor: 5.828

Review 4.  Palliative Care in End-Stage Liver Disease Patients Awaiting Liver Transplantation: Review.

Authors:  Sara Vieira Silva; Elga Freire; Helena Pessegueiro Miranda
Journal:  GE Port J Gastroenterol       Date:  2020-05-27

5.  Endothelin-1/Nitric Oxide Ratio as a Predictive Factor of Response to Therapy With Terlipressin and Albumin in Patients With Type-1 Hepatorenal Syndrome.

Authors:  Ahmed Abdel-Razik; Nasser Mousa; Mostafa Abdelsalam; Ahmed Abdelwahab; Mona Tawfik; Ahmed M Tawfik; Ahmad S Hasan; Rania Elhelaly; Niveen El-Wakeel; Waleed Eldars
Journal:  Front Pharmacol       Date:  2020-01-31       Impact factor: 5.810

6.  MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.

Authors:  Maria-Carlota Londoño; Andrés Cárdenas; Mónica Guevara; Llorenç Quintó; Dara de Las Heras; Miguel Navasa; Antoni Rimola; Juan-Carlos Garcia-Valdecasas; Vicente Arroyo; Pere Ginès
Journal:  Gut       Date:  2007-04-23       Impact factor: 23.059

7.  Update on the management of cirrhosis - focus on cost-effective preventative strategies.

Authors:  Guy W Neff; Nyingi Kemmer; Christopher Duncan; Angel Alsina
Journal:  Clinicoecon Outcomes Res       Date:  2013-04-12

8.  Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study.

Authors:  Fernando Gomes Romeiro; Fabio da Silva Yamashiro; Madileine Francely Américo; Luciana Aparecida Corá; Giovanni Faria Silva; José Ricardo de Arruda Miranda; Carlos Antonio Caramori
Journal:  BMC Gastroenterol       Date:  2013-01-16       Impact factor: 3.067

9.  Pulse oximeter oxygen saturation in prediction of arterial oxygen saturation in liver transplant candidates.

Authors:  Seiyed Mohammad Ali Ghayumi; Abolfazl Khalafi-Nezhad; Zahra Jowkar
Journal:  Hepat Mon       Date:  2014-04-07       Impact factor: 0.660

10.  Advanced Glycation End Products as a Predictor of Diabetes Mellitus in Chronic Hepatitis C-Related Cirrhosis.

Authors:  Ahmed Abdel-Razik; Nasser Mousa; Sahar Zakaria; Mostafa Abdelsalam; Mohamed Eissa; Mohammed I Abd El-Ghany; Ahmad S Hasan; Rania Elhelaly; Rasha Elzehery; Niveen El-Wakeel; Waleed Eldars
Journal:  Front Med (Lausanne)       Date:  2020-10-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.